Generic or Specific? The Frames of Stem Cell Procurement Regulation in Europe

Research output: Contribution to journalArticlepeer-review

Abstract (may include machine translation)

The procurement of stem cells, which is a crucial source-material in biomedical research promising the development of novel therapies in regenerative medicine, is subject to regulation using generic and technology-specific provisions throughout Europe. The relevant national regulatory regimes, while they share common regulatory frames, exhibit considerable differences as a matter of the regulatory approach followed, the biological level regulated, or of the context in which technologies for stem cell procurement are regulated. This variety indicates that legal regulation may resort to different means so as to secure a connection with the technology regulated. It is proposed that for improving “regulatory connection” states should consider engaging in regulatory borrowing from other systems covering both generic and specific instruments of technology regulation.
Original languageEnglish
Pages (from-to)37-80
Number of pages44
JournalScripted: a journal of law technology and society
Volume14
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Dive into the research topics of 'Generic or Specific? The Frames of Stem Cell Procurement Regulation in Europe'. Together they form a unique fingerprint.

Cite this